FFCP PHASE1:Mm9::chr14:75197493..75197500,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr14:75197493..75197500,+|id=chr14:75197493..75197500,+|ontology_enrichment_celltype=CL:0000945!1.78e-07!1;CL:0000236!1.78e-07!1;CL:0000826!1.78e-07!1;CL:0000355!4.94e-07!9|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=DOID:0060100!5.37e-20!3;DOID:4045!5.37e-20!3;DOID:0050686!2.68e-10!6|ontology_enrichment_disease_v019_2=DOID:0060100,1.31e-17,3;DOID:4045,1.31e-17,3;DOID:0050686,2.61e-09,6|ontology_enrichment_uberon=UBERON:0005631!1.10e-09!3;UBERON:0000478!1.10e-09!3;UBERON:0000158!1.10e-09!3;UBERON:0004871!3.19e-09!3;UBERON:0000305!9.86e-08!1;UBERON:0001134!4.94e-07!9;UBERON:0002036!4.94e-07!9;UBERON:0002385!4.94e-07!9;UBERON:0000486!4.94e-07!9;UBERON:0001015!4.94e-07!9;UBERON:0004290!4.94e-07!9;UBERON:0003082!4.94e-07!9|ontology_enrichment_uberon_v019_2=UBERON:0005631,1.31e-17,3;UBERON:0000478,1.31e-17,3;UBERON:0000158,1.31e-17,3;UBERON:0000305,1.55e-13,1;UBERON:0001987,1.14e-07,2;UBERON:0003124,1.14e-07,2;UBERON:0004340,1.14e-07,2|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.51118978442145,0.7813353445238,5.23523743973798,11.7646297606203,1.36609096991689,2.91306211818692,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0755715601067855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.73036477414062,0,0,0.161766849947409,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.51469581422943,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162135226775035,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.77862626764225,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr14:75197493..75197500,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr14:75197493..75197500,+ | |||
|description=CAGE_peak_at_chr14:75197493..75197500,+ | |||
|id=chr14:75197493..75197500,+ | |||
|ontology_enrichment_celltype=CL:0000945!1.78e-07!1;CL:0000236!1.78e-07!1;CL:0000826!1.78e-07!1;CL:0000355!4.94e-07!9 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease=DOID:0060100!5.37e-20!3;DOID:4045!5.37e-20!3;DOID:0050686!2.68e-10!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.31e-17,3;DOID:4045,1.31e-17,3;DOID:0050686,2.61e-09,6 | |||
|ontology_enrichment_uberon=UBERON:0005631!1.10e-09!3;UBERON:0000478!1.10e-09!3;UBERON:0000158!1.10e-09!3;UBERON:0004871!3.19e-09!3;UBERON:0000305!9.86e-08!1;UBERON:0001134!4.94e-07!9;UBERON:0002036!4.94e-07!9;UBERON:0002385!4.94e-07!9;UBERON:0000486!4.94e-07!9;UBERON:0001015!4.94e-07!9;UBERON:0004290!4.94e-07!9;UBERON:0003082!4.94e-07!9 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0005631,1.31e-17,3;UBERON:0000478,1.31e-17,3;UBERON:0000158,1.31e-17,3;UBERON:0000305,1.55e-13,1;UBERON:0001987,1.14e-07,2;UBERON:0003124,1.14e-07,2;UBERON:0004340,1.14e-07,2 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.51118978442145,0.7813353445238,5.23523743973798,11.7646297606203,1.36609096991689,2.91306211818692,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0755715601067855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.73036477414062,0,0,0.161766849947409,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.51469581422943,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162135226775035,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.77862626764225,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr14:75197493..75197500,+ | |||
}} |
Latest revision as of 19:32, 4 August 2015
Short description: | p@chr14:75197493..75197500, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr14:75197493..75197500, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
extraembryonic membrane | 1.31e-17 | 3 |
extraembryonic structure | 1.31e-17 | 3 |
membranous layer | 1.31e-17 | 3 |
amnion | 1.55e-13 | 1 |
placenta | 1.14e-07 | 2 |
chorion | 1.14e-07 | 2 |
allantois | 1.14e-07 | 2 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.31e-17 | 3 |
muscle cancer | 1.31e-17 | 3 |
organ system cancer | 2.61e-09 | 6 |